Seasoned C-level executive with extensive experience in pharmaceuticals, healthcare, and international markets, specialising in commercial strategy, business transformation, and multi-market operations across Europe, CEE, and CIS. Brings deep expertise in P&L leadership, market expansion, M&A, and go-to-market execution, with a strong track record in driving revenue growth, optimising portfolios, and building scalable commercial organisations. Proven capability in leading complex transformations, integrating acquisitions, and delivering sustainable performance in dynamic and highly regulated environments.

Recognised for hands-on, results-driven leadership with the ability to build aligned, high-performing teams and navigate complex stakeholder landscapes. Combines strategic vision with pragmatic execution, influencing boards, investors, and senior leadership to deliver long-term value. Known for fostering collaboration, driving accountability, and translating strategy into measurable outcomes across diverse international markets.

Speaks 7 European languages including fluent Russian.

• Since Sep. 2025 — Partner, Pharmalicensing One, LLC Manage BD&L and M&A projects in ex-USSR, the Balkans, MENA and RoW.
• 2020 — 2025 — General Manager Russia & CIS, Aristo Pharma, LLC
• 2008 — present — Managing Director, Avanu Consulting, Cyprus